epigallocatechin gallate has been researched along with Cardiovascular Stroke in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 4 (30.77) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Gan, X; Jian, J; Liang, R; Wang, R; Yu, Q; Zhang, N | 1 |
Guo, QH; Liu, JJ; Liu, Y; Wei, XY; Yin, N; Zeng, WJ; Zeng, YF | 1 |
Li, P; Qin, T; Sun, D; Wang, J; Zhang, B; Zhao, X | 1 |
He, H; He, S; Jiang, Q; Jiao, Y; Tu, Q; Xu, M; Zheng, W | 1 |
Chen, ZZ; Dou, J; Lei, SQ; Leng, Y; Meng, QT; Wu, Y; Xia, ZY; Zhao, B; Zhu, J | 1 |
Chang, H; Lin, CM; Shyu, KG; Wang, BW | 1 |
Dardor, M; El-Missiry, MA; Elkomy, MM; Othman, AI | 1 |
Devika, PT; Stanely Mainzen Prince, P | 3 |
Chun, KJ; Jang, Y; Kim, JH; Lee, D; Song, DK; Xu, Z | 1 |
Gitti, G; Knight, RA; Latchman, DS; Menegazzi, M; Pasini, E; Scarabelli, TM; Stephanou, A; Suzuki, H; Townsend, PA | 1 |
Devika, PT; Prince, PS | 1 |
1 review(s) available for epigallocatechin gallate and Cardiovascular Stroke
Article | Year |
---|---|
Cardioprotective effect of epigallocatechin gallate in myocardial ischemia/reperfusion injury and myocardial infarction: a meta-analysis in preclinical animal studies.
Topics: Animals; Animals, Laboratory; Catechin; Myocardial Infarction; Myocardial Reperfusion Injury | 2023 |
12 other study(ies) available for epigallocatechin gallate and Cardiovascular Stroke
Article | Year |
---|---|
EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis.
Topics: Animals; Catechin; Disease Models, Animal; Mice; MicroRNAs; Myocardial Infarction; Myocardial Ischemia | 2023 |
Protective effect of epigallocatechin-3-gallate against neuroinflammation and anxiety-like behavior in a rat model of myocardial infarction.
Topics: Animals; Anxiety; Apoptosis; Catechin; Hippocampus; Myocardial Infarction; Rats | 2020 |
EGCG decreases myocardial infarction in both I/R and MIRI rats through reducing intracellular Ca2+ and increasing TnT levels in cardiomyocytes.
Topics: Animals; Apoptosis; Calcium; Catechin; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Troponin T | 2021 |
(-)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions.
Topics: Animals; Apoptosis; Cardiotonic Agents; Catechin; Diabetes Mellitus, Experimental; Hyperglycemia; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Sirtuin 1; Superoxide Dismutase | 2017 |
Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo.
Topics: Angiotensin II; Animals; Anthracenes; Catechin; Cell Proliferation; Cells, Cultured; Endoglin; Fibrosis; Heart Failure; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Models, Biological; Myocardial Infarction; Myocardium; Promoter Regions, Genetic; Protein Binding; Rats, Wistar; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1 | 2016 |
Epigallocatechin-3-gallate prevents cardiac apoptosis by modulating the intrinsic apoptotic pathway in isoproterenol-induced myocardial infarction.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Body Weight; Catechin; Cytoprotection; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar | 2017 |
(-)Epigallocatechingallate protects the mitochondria against the deleterious effects of lipids, calcium and adenosine triphosphate in isoproterenol induced myocardial infarcted male Wistar rats.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Calcium; Catechin; Cholesterol; Fatty Acids, Nonesterified; Isoproterenol; Lipid Peroxides; Lipids; Male; Mitochondria, Heart; Myocardial Infarction; Phospholipids; Protective Agents; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Thiobarbituric Acid Reactive Substances; Triglycerides | 2008 |
Polyphenol (-)-epigallocatechin gallate during ischemia limits infarct size via mitochondrial K(ATP) channel activation in isolated rat hearts.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Catechin; Decanoic Acids; Glyburide; Heart; Hemodynamics; Humans; Hydroxy Acids; KATP Channels; Male; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Potassium Channel Blockers; Rats; Rats, Wistar | 2010 |
Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis.
Topics: Administration, Oral; Animals; Animals, Newborn; Apoptosis; Caspases; Catechin; Cell Survival; Cells, Cultured; DNA-Binding Proteins; Enzyme Activation; Heart; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Phosphorylation; Plant Extracts; Rats; Reperfusion Injury; STAT1 Transcription Factor; Tea; Trans-Activators | 2004 |
Protective effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: a histopathological study.
Topics: Animals; Catechin; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar | 2008 |
Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats.
Topics: Animals; Cardiovascular Agents; Catechin; Disease Models, Animal; Heart; Isoproterenol; Lysosomes; Male; Myocardial Infarction; Rats; Rats, Wistar; Subcellular Fractions; Time Factors | 2008 |
(-)Epigallocatechin-gallate (EGCG) prevents mitochondrial damage in isoproterenol-induced cardiac toxicity in albino Wistar rats: a transmission electron microscopic and in vitro study.
Topics: Animals; Antioxidants; Catalase; Catechin; Free Radical Scavengers; Glutathione; In Vitro Techniques; Isoproterenol; Lipid Peroxides; Male; Microscopy, Electron, Transmission; Mitochondria, Heart; Myocardial Infarction; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2008 |